The global D-4-Hydroxyphenylglycine market size is predicted to grow from US$ 239 million in 2025 to US$ 294 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.

D-4-Hydroxyphenylglycine is a pharmaceutical fine chemical with the appearance of white crystalline powder. Its molecular formula is C8H9NO3, and its melting point is 240 ? (decomposition). It is slightly soluble in water and methanol, and easily soluble in acid or alkaline solutions to form salts.

United States market for D-4-Hydroxyphenylglycine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for D-4-Hydroxyphenylglycine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for D-4-Hydroxyphenylglycine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key D-4-Hydroxyphenylglycine players cover Apeloa Pharmaceutical, Newland Pharmaceutical, DSM, Kaneka Corporation, The United Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the D-4-Hydroxyphenylglycine Industry Forecast looks at past sales and reviews total world D-4-Hydroxyphenylglycine sales in 2024, providing a comprehensive analysis by region and market sector of projected D-4-Hydroxyphenylglycine sales for 2025 through 2031. With D-4-Hydroxyphenylglycine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world D-4-Hydroxyphenylglycine industry.

This Insight Report provides a comprehensive analysis of the global D-4-Hydroxyphenylglycine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on D-4-Hydroxyphenylglycine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global D-4-Hydroxyphenylglycine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for D-4-Hydroxyphenylglycine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global D-4-Hydroxyphenylglycine.

This report presents a comprehensive overview, market shares, and growth opportunities of D-4-Hydroxyphenylglycine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Chemical Method
    Enzymatic Method

Segmentation by Application:

    Penicillins
    Cephalosporins
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Apeloa Pharmaceutical
    Newland Pharmaceutical
    DSM
    Kaneka Corporation
    The United Laboratories
    Zhejiang Yuntao Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global D-4-Hydroxyphenylglycine market?
What factors are driving D-4-Hydroxyphenylglycine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do D-4-Hydroxyphenylglycine market opportunities vary by end market size?
How does D-4-Hydroxyphenylglycine break out by Type, by Application?